Skip to content

Improving Outpatient Colonoscopy Bowel Prep with the Orton Score

Validation of a Novel Clinical Prediction Scoring System for Improved Bowel Preparation Prior to Outpatient Colonoscopy

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04093557
Enrollment
0
Registered
2019-09-18
Start date
2024-12-06
Completion date
2024-12-06
Last updated
2024-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon Cancer, Colonic Polyp

Keywords

colonoscopy, bowel prep, screening

Brief summary

Colonoscopy is a common endoscopic procedure which the UVA Gastroenterology & Hepatology department performs on a daily basis for both screening/surveillance and diagnostic/therapeutic intent. As a safety net hospital, the institution also offers open access colonoscopy as a means of allowing outside primary care and urgent care providers a way to have patients receive necessary endoscopy services. However, these patients are not all seen in clinic prior to their procedure but are all prescribed a specific bowel prep by a medical professional who screens the referrals. Given that the patient population described above are often not well-known to UVA providers, they may be prescribed prep regimens that are not ideal for their comorbidities. Not infrequently, these patients show up to their colonoscopies with an inadequate bowel prep, leading to either cancelled or incomplete procedures, increased healthcare and personal financial costs (such as missed wages from taking off work), suboptimal endoscopy resource utilization, and delay in or missed polyp (or potentially cancer) detection. The investigators seek to use a novel scoring system designed to predict patients at risk for suboptimal preps (and hence patients that would benefit from an extended prep) and apply it in uniform fashion to a patient population most at risk for suboptimal preps. Because obtaining written consent is not practical given that these patients may not be seen by a UVA provider prior to their endoscopic procedure, the investigators will plan to verbally consent via the telephone in an all-inclusive manner; there will be no randomization but rather the selection of prep to be determined by the novel scoring system. Subjects be prescribed either a standard split-dose GoLytely prep (or SuPrep) or an extended split-dose GoLytely prep. The investigators predict that utilizing this new system will lead to a decreased number of inadequate bowel preps and will increase polyp detection. The investigators will work with a UVA biostatistician to analyze the data and use Chi Square, student's T tests, and logistic regression models to assess significance and help validate the model.

Interventions

OTHEROrton Score

Significant a priori predictors of poor prep included: male gender, COPD, diabetes with end-organ damage, severe neurologic disease, constipation medication use, and tricyclic antidepressant use. Proprietary web-based weighted scoring model allows screening clinician to predict which bowel prep would be best for patient depending on which risk factors patients have.

OTHERTypical Standard of Care

Clinician usual practice of prescribing bowel preps to patient

Sponsors

University of Virginia
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
NONE

Intervention model description

All patients will be assessed for the most appropriate bowel preparation prior to colonoscopy (standard vs. extended) based on a novel scoring tool that accounts for various clinical conditions.

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 18 or older (up to 100 years) * Referred for open access colonoscopy from an outside provider/UVA provider * Able to provide informed consent

Exclusion criteria

* Prisoners

Design outcomes

Primary

MeasureTime frameDescription
Inadequate prep rateThrough study duration, approximately 1 yearPercentage of colonoscopies where performing endoscopist rates the prep as inadequate for intended purpose (screening/surveillance)

Secondary

MeasureTime frameDescription
Adenoma detection rate (ADR)Through study duration, approximately 1 yearPercentage of colonoscopies with detection of at least 1 adenoma
Polyp burdenThrough study duration, approximately 1 yearMean # of polyps found per colonoscopy
Advanced adenoma / adenocarcinoma detection rateThrough study duration, approximately 1 yearPercentage of colonoscopies with detection of an adenoma with high-grade dysplasia, tubulovillous adenoma, or adenocarcinoma
Incomplete colonoscopy rateThrough study duration, approximately 1 yearPercentage of colonoscopies that are unable to be completed secondary to inadequate prep or technical difficulty

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026